Exagen Inc. (XGN)
NASDAQ: XGN · IEX Real-Time Price · USD
1.980
+0.050 (2.59%)
Jul 22, 2024, 10:53 AM EDT - Market open
Exagen Employees
As of December 31, 2023, Exagen had 179 total employees, including 174 full-time and 5 part-time employees. The number of employees decreased by 25 or -12.25% compared to the previous year.
Employees
179
Change (1Y)
-25
Growth (1Y)
-12.25%
Revenue / Employee
$311,358
Profits / Employee
-$108,162
Market Cap
34.05M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Nutex Health | 800 |
Achilles Therapeutics | 215 |
Retractable Technologies | 151 |
Orgenesis | 146 |
iCAD, Inc. | 69 |
Immuneering | 68 |
IGC Pharma | 67 |
Unicycive Therapeutics | 14 |
XGN News
- 2 hours ago - Exagen to Announce Second Quarter 2024 Results on August 5, 2024 - GlobeNewsWire
- 5 weeks ago - Time to Play 5 Top-Ranked Stocks With Rising P/E? - Benzinga
- 2 months ago - Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year - GlobeNewsWire
- 2 months ago - Exagen to Announce First Quarter 2024 Results on May 13, 2024 - GlobeNewsWire
- 3 months ago - Exagen Inc. Announces Changes to the Board of Directors - GlobeNewsWire
- 4 months ago - Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results - GlobeNewsWire
- 4 months ago - Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum - GlobeNewsWire
- 4 months ago - Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024 - GlobeNewsWire